This is a list of some of the papers, including links to abstracts,

published by members of the International Albinism Center.

  1. Oetting WS, Garrett SS, Brott M, King RA, 2005, P gene mutations associated with oculocutaneous albinism type II (OCA2). Human Mutation (in press).
  2. Anderson J, Lavoie J, Merrill K, King RA, Summers CG. 2004, Efficacy of spectacles in persons with albinism. Journal of the American Association of Pediatric Ophthalmology and Strabismus, 8:515-20. [Link to abstract]
  3. Merrill KS, Lavoie JD, King RA, Summers CG. 2004, Positive angle kappa in albinism. Journal of the American Association of Pediatric Ophthalmology and Strabismus, 8:237-9. [Link to abstract]
  4. Oetting WS, 2003, Albinism: Genetics, in Nature Encyclopedia of the Human Genome, Nature Publishing Group, London.
  5. Yi Z, Garrison N, Cohen-Barak O, Karafet TM, King RA, Erickson RP, Hammer MF, Brilliant MH. 2003, A 122.5-kilobase deletion of the P gene underlies the high prevalence of oculocutaneous albinism type 2 in the Navajo population. American Journal of Human Genetics 72:62-72. [Link to abstract]
  6. Bahadoran P, Ortonne J-P, King RA, Oetting WS, 2003, Albinism, in Fitzpatrick's Dermatology in General Medcine, 6th edition, Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz, SI (eds), McGraw-Hill, New York, pp. 826-836.
  7. Young TL, Guo XD, King RA, Johnson JM, Rada JA. 2003, Identification of genes expressed in a human scleral cDNA library. Molecular Vision 9:508-14. [Link to abstract]
  8. King RA, 2003, Oculocutaneous Albinism Type 1, GeneReviews. [http://www.geneclinics.org/profiles/oca1]
  9. King RA, Oetting WS, 2003, Oculocutaneous Albinism Type 2, GeneReviews. [http://www.geneclinics.org/profiles/oca2]
  10. Fryer JP, Oetting WS, King RA. 2003, Identification and characterization of a DNase hypersensitive region of the human tyrosinase gene. Pigment Cell Research 16:679-684. [Link to abstract]
  11. King RA, Pietsch J, Fryer JP, Savage S, Brott MJ, Russell-Eggitt I, Summers CG, Oetting WS, 2003, Tyrosinase gene mutations in oculocutaneous albinism (OCA1): Definition of the phenotype. Human Genetics 113:502-13. [Link to abstract]
  12. King RA, Willaert RK, Schmidt RM, Pietsch J, Savage S, Brott MJ, Fryer JP, Summers CG, Oetting WS, 2003, MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2). American Journal of Human Genetics 73:638-645. [Link to abstract]
  13. Oetting WS, Fryer JP, Shiriam S, King RA, 2003, Oculocutaneous albinism type I: The last 100 years. Pigment Cell Research 16:307-11. [Link to abstract]
  14. Oetting WS, 2002, New insight into Ocular Albinism Type 1 (OA1): Mutations and polymorphisms of the OA1 gene. Human Mutation 19:85-92. [Link to abstract]
  15. Whang SJ, King RA, Summers CG. 2002, Grating acuity in albinism in the first three years of life. Journal of the American Association of Pediatric Ophthalmology and Strabismus 6:393-6. [Link to abstract]
  16. King RA, Oetting WS, Summers CG, Creel DJ, Hearing VJ, 2001, Abnormalities of Pigmentation, in Principles and Practice of Medical Genetics, 4th edition, Rimoin DL, Connor JM, Pyeritz RE Korf BR (eds), Churchill Livingstone, Edinburgh, pp. 3731-3785.
  17. Newton JM, Cohen-Barak O, Hagiwara N, Gardner JM, Davisson MT, King RA, Brilliant MH. 2001, Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4. American Journal of Human Genetics 69:981-8. [Link to abstract]
  18. Fryer JP, Oetting WS, Brott MJ, King RA. 2001, Alternative splicing of the tyrosinase gene transcript in normal human melanocytes and lymphocytes. Journal of Investigative Dermatology 117:1261-1265. [Link to abstract]
  19. Lee KA, King RA, Summers CG. 2001, Stereopsis in patients with albinism: clinical correlates. Journal of the American Association of Pediatric Ophthalmology and Strabismus 5:98-104. [link to abstract]
  20. Oetting WS, Armstrong C, Holleschau A, DeWan AT, Summers CG, 2000, Evidence for genetic heterogenity in families with congenital motor nystagmus (CN). Ophthalmic Genetics 21:227-233. [Link to abstract]
  21. Oetting WS, 2000, The tyrosinase gene and oculocutaneous albinism type I (OCA1): A model for understanding the molecular biology of melanin formation. Pigment Cell Research 13:320-325. [Link to abstract]
  22. Oetting WS. 2000, Gene Expression Analysis. Pigment Cell Research 13:21-27. [Link to abstract]
  23. King RA, Hearing VJ, Creel D, Oetting WS. 2000, Albinism, in The Metabolic and Molecular Basis of Inherited Disease, 8th edition, Scriver CR, Beaudet AL, Sly WS, Valle D (eds), McGraw-Hill, New York, pp. 5587-5627.
  24. Oetting WS, 1999, Albinism. Current Opinion in Pediatrics 11:565-71. [Link to abstract]
  25. Oetting WS, King RA. 1999, Molecular basis of albinism: Mutations and polymorphisms of pigmentation genes associated with albinism. Human Mutations 13:99-115. [Link to abstract]
  26. King RA, Oetting WS, 1999, Albinism, in Fitzpatrick's Dermatology in General Medcine, Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz, SI, Fitzpatrick TB (eds), McGraw-Hill, New York, pp925-936.
  27. Tripathi RK, Flanders DJ, Young TL, Oetting WS, Ramaiah A, King RA, Boissy RE, Nordlund JJ, 1999, Microphthalmia-associated transcription factor (MITF) locus lacks linkage to human vitiligo or osteopetrosis: An evaluation. Pigment Cell Research 12:187-192. [Link to abstract]
  28. Oetting WS, Gardner JM, Fryer JP, Ching A, Durham-Pierre D, King RA, Brilliant MH. 1998, Mutations of the human P gene associated with type II oculocutaneous albinism (OCA2). Human Mutations 12:434. http://journals.wiley.com/1059-7794/pdf/mutation/205.pdf. [Link to abstract]
  29. Oetting WS, Fryer JP, King RA. 1998, Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Human Mutations 12:433-434. http://journals.wiley.com/1059-7794/pdf/mutation/204.pdf. [Link to abstract]
  30. Wildenberg SC, Fryer JP, Gardner JM, Oetting WS, Mao J-I, Brilliant MH, King RA, 1998, Identification of a novel transcript produced by the gene responsible for the Hermansky-Pudlak Syndrome in Puerto Rico, Journal of Investigative Dermatology 110:777-781. [Link to abstract]
  31. Lund PM, Puri N, Durham-Pierre D, King RA, Brilliant MH, 1997, Oculocutaneous albinism in an isolated Tonga community in Zimbabwe, Journal of Medical Genetics 34:733-735. [Link to abstract]
  32. Hazelwood S, Shotelersuk V, Wildenberg SC, Chen D, Iwata F, Kaiser-Kupfer MI, White JG, King RA, Gahl, 1997, Evidence for locus heterogeneity in Puerto Ricans with Mermansky-Pudlak syndrome, American Journal of Human Genetics 61:1088-1094. [Link to abstract]
  33. Oetting WS, 1997, Anatomy of Pigment Genes Acting at the Subcellular Level, in The Pigmentary System and its Disorders, Nordlund JJ, Boissy R, Hearing V, King R, Ortonne J-P (eds), Oxford University Press, New York pp. 231-249.
  34. Oetting WS, King RA, 1997, Molecular Approaches to the Study of the Pigment Cell, in The Pigmentary System and its Disorders, Nordlund JJ, Boissy R, Hearing V, King R, Ortonne J-P (eds), Oxford University Press, New York pp. 201-206.
  35. Puri N, Durham-Pierre D, Aquaron R, Lung PM, King RA, Brilliant MH, 1997, Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: distribution of the 2.7 kb deletion allele of the P gene. Human Genetics100:651-656 [Link to abstract]
  36. Gardner JG, Wildenberg SC, Keiper NM, Novak EK, Rusiniak ME, Swank RT, Puri N, Finger JN, Hagiwara N, Lehman AL, Gales T, Bayer ME, King RA, Brilliant MH, 1997, The mouse pale ear (ep) mutation is the homologue of human Hermansky-Pudlak syndrome (HPS). Proceedings of the National Academy of Sciences USA,94:9238-9243. [Link to abstract]
  37. King RA, Hearing VJ, Creel DJ, Oetting WS, 1996, Abnormalities of Pigmentation, in Principles and Practice of Medical Genetics, Emery AEH and Rimoin DL (eds), Churchill Livingstone, Edinburgh, pp 1171-1203.
  38. Oetting WS, Wildenberg SC, Brilliant MH, Fryer JP, King RA, 1996, Molecular genetics of normal and abnormal melanogenesis. Excerpta Medica International Congress Series 1096, pp. 7-16.
  39. Oetting WS, Wildenberg SC, King RA, 1996, Genetic linkage analysis using pooled DNA and Infrared Detection of Tailed STRP Primer Patterns, in Ultrasensitive Biochemical Diagnostics, GE Cohn, S A Soper and CHW Chen, Eds, Proc. SPIE, 2680, pp. 226-234.
  40. Summers CG, 1996, Vision in albinism. Transactions of the American Ophthalmologic Society 94:1095-155. [Link to abstract]
  41. Boissy RE, Zhao H, Oetting WS, Kobayashi T, Austin LA, Wildenberg SC, Boissy YL, Zhao Y, Hearing VJ, King RA, Nordlund, 1996, Mutations in and lack of expression of tyrosinase related protein-1 (TRP-1) in melanocytes from an individual with tyrsosinase-positive oculocutaneous albinism; A new subtype of albinism classified as OCA3. American Journal of Human Genetics 58:1145-1156. [Link to abstract]
  42. Oetting WS, Brilliant, M, King RA, 1996, The clinical spectrum of albinism in humans. Molecular Medicine Today 2:330-335. [Link to abstract]
  43. Summers CG, Oetting WS, King RA, 1996, Diagnosis of oculocutaneous albinism with Molecular analysis. American Journal of Ophthalmology 121:724-726. [Link to abstract]
  44. Reish O, Hirsch B and King RA, 1996, Letter -- Angelman syndrome at an older age. American Journal of Medical Genetics 61:21-25. [Link to abstract]
  45. Durham-Pierre D, King RA, Naber JM, Laken S and Brilliant MH, 1996, Estimation of the carrier frequency of 2.7 kb deletion allele of the P gene associated with OCA2 in African Americans. Human Mutation 7:370-373. [Link to abstract]
  46. Oetting WS, Wildenberg SC, Brilliant MH, Fryer JP, King RA, 1995, Molecular genetics of normal and abnormal melanogenesis, in International Symposium on Melanogenesis and Malignant Melanoma, Hori Y., Hearing VJ, Nakayama J (eds), Elsevier Science B.V., The Netherlands, pp 7-16.
  47. King RA, Hearing VJ, Creel D, Oetting WS, 1995, Albinism, in The Metabolic and Molecular Basis of Inherited Disease, 7th edition, Scriver CR, Beaudet AL, Sly WS, Valle D (eds), McGraw-Hill, New York, pp. 4353-4392.
  48. Oetting WS, Lee H, Flanders D, Wiesner G, Sellers T, King RA, 1995, Linkage analysis with multiplexed short tandem repeat polymorphisms using infrared fluorescence and M13 tailed primers. Genomics 30:450-458. [Link to abstract]
  49. Wildenberg SC, King RA, Oetting WS, 1995, Detection of a Tsp509 I polymorphism in the 3'UTR of the human tyrosinase related protein-1 (TYRP) gene, Human Genetics 95:247. [Link to abstract]
  50. Reish O, Berry SA, King RA, 1995, Spontaneous hair hyperpigmentation in response to vitamin intake in pregnancy--a clue for homocystinuria, American Journal of Obstetrics & Gynecology 173:1640-1641. [Link to abstract]
  51. Reish O, Townsend DW, Berry SA, Tsai MY and King RA, 1995, Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency, American Journal of Human Genetics 57:127-132. [Link to abstract]
  52. Wildenberg SC, Oetting WS, Almadovar C, Krumwiede M, White JG, King RA, 1995, A gene causing Hermansky-Pudlak syndrome in a Puerto Rican population maps to Chromosome 10q2. American Journal of Human Genetics 57:755-765. [Link to abstract]
  53. Oetting WS, Fryer JP, Oofuji Y, Middendorf LR, Brumbaugh JA, Summers CG, King RA, 1994, Analysis of tyrosinase gene mutations using direct automated infrared fluorescence DNA sequencing of amplified exons. Electrophoresis 15:159-164. [Link to abstract]
  54. Oetting WS, King RA, 1994, The molecular basis of oculocutaneous albinism. Journal of Investigative Dermatology 103:131s-136s. [Link to abstract]
  55. Brilliant MH, King RA, Franke U, Meitinger T, Gardner JM, Durham-Pierre D and Nakatsu Y, 1994, The mouse pink-eyed dilution gene: Association with hypopigmentation in Prader-Willi and Angelman syndromes, and with human OCA2. Pigment Cell Research 7:398-402.
  56. Durham-Pierre D, Gardner JM, Nakatsu Y, King RA, Francke U, Ching A, Aquaron R, del Marmol V and Brilliant MH, 1994, African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism. Nature Genetics 7:176-179. [Link to abstract]
  57. Zhao H, Boissy YL, Abdel-Malek Z, King RA, Nordlund JJ and Boissy RE, 1994, On the analysis of the pathophysioloy of Chediak-Higashi Syndrome: Defects expressed by cultured melanocytes. Laboratory Investigation 71:25-34. [Link to abstract]
  58. Summers CG and King RA, 1994, Opthalmic features of minimumal pigment oculocutaneous albinism. Opthalmology 101:906-914. [Link to abstract]
  59. Harmon KR, Witkop CJ, White JG, King RA, Peterson M, Moore D, Tashjian J, Marinelli W and Bitterman P, 1994, Pathogenesis of pulmonary fibrosis - PDGF precedes structural alterations in the Hermansky-Pudlak syndrome. Journal of Laboratory and Clinical Medicine 123:617-627. [Link to abstract]
  60. Oetting WS, King RA, 1994, Analysis of the mutations associated with tyrosinase related oculocutaneous albinism (OCA1). Pigment Cell Research 7:285-290. [Link to abstract]
  61. King RA, Jackson IJ, Oetting WS, 1994, Human Albinism and Mouse Models, in The Molecular Genetics of Inherited Eye Disorders, Wright AF, Jay B (eds), Harwood, Switzerland, pp. 89-122.
  62. Oetting WS, Summers CG, King RA, 1994, Albinism and its relationship to the ocular defects. Metabolic, Pediatric and Systemic Ophthalmology 17:5-9. [Link to abstract]
  63. Oetting WS, Witkop CJ, Brown S, Colomer R, Fryer J, Bloom KE, King RA, 1993, A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico. American Journal of Human Genetics 52:17-23. [Link to abstract]
  64. Oetting WS, King RA, 1993, Molecular Basis of Type I (Tyrosinase-Related) Oculocutaneous Albinism: Mutations and Polymorphisms of the Human Tyrosinase Gene. Human Mutations 2:1-7. [Link to abstract]
  65. Oetting WS, Fryer JP, King RA, 1993, A dinucleotide deletion (-DGA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual. Human Molecular Genetics 2:1047-1048. [Link to abstract]
  66. Oetting WS, Steine OC, Townsend D, King RA, 1993, Evolution of the tyrosinase related gene (TYRL) in primates. Pigment Cell Research 6: 171-177. [Link to abstract]
  67. King RA, Townsend D, Oetting WS, 1993, Inherited Hypopigmentary Disorders, in Pigmentation and Pigmentary Abnormalities, Levine, N (ed), CRC Press Inc., Boca Raton, pp 297-336.
  68. Hearing VJ and King RA, 1993, Determinants of Skin Color: Melanocytes and Melanization, in Pigmentation and Pigmentary Abnormalities, Levine, N (ed), CRC Press Inc., Boca Raton, pp. 3-32.
  69. King RA, Wiesner G, Townsend D and White JG, 1993, Hypopigmentation in Angelman syndrome. American Journal of Medical Genetics 46:40-44. [Link to abstract]
  70. King RA, Rotter JI, Motulsky AG eds. 1992, The Genetic Basis of Common Diseases Oxford University Press, New York.
  71. King RA, 1992, Albinism, in Dermatology in General Medicine, Fourth Edition. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM and Austen KF (eds): McGraw-Hill, New York, pp. 912-921.
  72. Gardner JM, Nakatsu Y, Gondo Y, Lee S, Lyon MF, King RA, Brilliant MH, 1992, The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromes. Science 257:1121-1124. [Link to abstract]
  73. King RA, Oetting WS, 1992, Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism. Pigment Cell Research S2:249-253. [Link to abstract]
  74. Townsend D, Oetting W, Polman T, King RA, 1992, Purification and characterization of dopachrome tautomerase (DT). Pigment Cell Research S2:32-35. [Link to abstract]
  75. Oetting WS, King RA, 1992, Molecular analysis of Type I-A (tyrosinase negative) oculocutaneous albinism. Human Genetics 90:258-262. [Link to abstract]
  76. Cheong PYY, Bateman JB, King RA, 1992, Oculocutaneous albinism: Variable expressivity of nystagmus in a sibship. Journal of Pediatric Ophthalmology and Strabismus 29:185-188. [Link to abstract]
  77. Oetting WS, King RA, 1992, Analysis of mutations in the Copper B binding region associated with type I (tyrosinase related) oculocutaneous albinism. Pigment Cell Research 5:274-278. [Link to abstract]
  78. Oetting WS, Roed CM, Mentink MM, Handoko HY, King RA, 1991, PCR detection of a TaqI polymorphism at the CCAATT box of the human tyrosinase (TYR) gene. Nucleic Acids Research, 19:5800. [Link to abstract]
  79. King RA, Townsend D, Oetting W, Summers CG, Olds D, White JG, Spritz RA, 1991, Temperature sensitive tyrosinase associated with peripheral pigment in oculocutaneous albinism. Journal of Clinical Investigation 87:1046-1053. [Link to abstract]
  80. Summers CG, Creel DJ, Townsend D, King RA, 1991, Variable expression of vision in sibs with albinism. American Journal of Medical Genetics 40:327-331. [Link to abstract]
  81. King RA, Mentink MM, Oetting WS, 1991, Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism. Molecular and Biological Medicine 8:19-30. [Link to abstract]
  82. Oetting WS, Mentink MM, Summers CG, Lewis RA, White JG, King RA, 1991, Three different frameshift mutations within the human tyrosinase gene in type IA oculocutaneous albinism. American Journal of Human Genetics 49:199-206. [Link to abstract]
  83. Oetting WS, Handoko HY, Mentink MM, Paller AS, White JG, King RA, 1991, Molecular analysis of an extended family with type IA (tyrosinase negative) oculocutaneous albinism. Journal of Investigative Dermatology 97:15-19. [Link to abstract]
  84. Giebel LB, Tripathi RK, Strunk KM, Hanifin JM, Jackson CE, King RA, Spritz RA, 1991, Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism. American Journal of Human Genetics 48:1159-1167. [Link to abstract]
  85. Giebel LB, Tripathi RK, King RA, Spritz RA, 1991, A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. Journal of Clinical Investigation 87:1119-1122. [Link to abstract]
  86. Witkop CJ, Nunez Babcock M, Rao GHR, Gaudier F, Summers CG, Shanahan F, Harmon KR, Townsend D, Sedano HO, King RA, Cal SX, White JG, 1990, Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bulli Asoc Medicine Puerto Rico 82:333-339. [Link to abstract]
  87. Oetting WS, Brumbaugh JA, 1990, The domestic fowl as an animal model for human albinism, in Nonmammalian Animal Models for Biomedical Research, Woodhead AD (ed), CRC Press Inc, Boca Raton, pp. 332-350.
  88. Spritz RA, Strunk KM, Giebel LB, King RA, 1990, Detection of mutations in the tyrosinase gene in a patient with Type IA oculocutaneous albinism. New England Journal of Medicine 322:1724-1728. [Link to abstract]
  89. Giebel LB, Strunk KM, King RA, Hanifin JM, Spritz RA, 1990, A frequent tyrosinase gene mutation in classic, tyrosinase- negative (Type IA) oculocutaneous albinism. Proceedings of the National Academy of Sciences USA 87:3255-3258. [Link to abstract]
  90. Creel DJ, Summers CG, King RA, 1990, Visual anomalies associated with albinism. Ophthalmic Paediatric Genetics 11:193-200. [Link to abstract]
  91. Witkop CJ, Quevedo WC, Fitzpatrick TB, and King RA, 1989, Albinism. in The Metabolic Basis of Inherited Diseases Scriver CR, Beaudet AL, Sly WS, and Valle D, (eds), McGraw-Hill, New York pp. 2905-2947.
  92. Summers CG, Knobloch WH, Witkop CJ, King RA, 1988, Hermansky-Pudlak syndrome: Ophthalmic findings. Ophthalmology 95:545-554. [Link to abstract]
  93. Spritz RA, Strunk KM, Oetting WS, King RA, 1988, RFLP for TaqI at the human tyrosinase locus. Nucleic Acids Research 16:9890. [Link to abstract]
  94. Shanahan F, Randolph L, King R, Oseas R, Brogan M, Witkop C, Rotter J, Targan S, 1988, The Hermansky-Pudlak syndrome: An immunological assessment of 15 cases. American Journal of Medicine 85:823-828.
  95. Leonard LJ, Townsend D, King RA, 1988, Function of DOPAchrome oxidoreductase and metal ions in DOPAchrome conversion in the eumelanin pathway. Biochemistry 27:6156-6159. [Link to abstract]
  96. Oetting WS, Smith GL, Brumbaugh JA, 1988, Isolation of pigment genes using retroviral insertional mutagenesis, in Advances in Pigment Cell Research, Bagnera J (ed), Alan R. Liss, New York, pp. 307-321. [Link to abstract]
  97. King, R. A., Olds, D. P., and Townsend, D, 1988, Mechanisms of Hypopigmentation in Human Oculocutaneous Albinism. in Advances in Pigment Cell Biology, Bagnara, J. T.,(ed), Alan R. Liss, New York pp. 183-191 [Link to abstract]
  98. King RA, Summers CG, 1988, Albinism. Dermatologica Clinica 6:217-228. [Link to abstract]
  99. Wiesner GL, Bendel CM, Olds DP, White JG, Arthur DC, Ball DW, King RA, 1987, Hypopigmentation in the Prader-Willi syndrome. American Journal of Human Genetics 40:431-442. [Link to abstract]
  100. Creel DJ, Bendel CM, Wiesner GL, Wirtschafter JD, Arthur DC, King RA, 1986, Abnormalities of the central visual pathways in Prader-Willi Syndrome associate with hypopigmentation. New England Journal of Medicine 314:1606-1609. [Link to abstract]
  101. King RA, Rich SS, 1986, Segregation analysis of brown oculocutaneous albinism. Clinical Genetics 29:496-501. [Link to abstract]
  102. King RA, Wirtschafter JD, Olds DP, Brumbaugh JA, 1986, Minimal pigment: a new type of oculocutaneous albinism. Clinical Genetics 29:42-50. [Link to abstract]
  103. Townsend D, Olds DP, King RA, 1986, DOPA oxidase activity in human hairbulbs measured by high- performance liquid chromatograpy. Journal of Investigative Dermatology 86:570-572. [Link to abstract]
  104. Barber JI, Townsend D, Olds DP, King RA, 1985, Decreased DOPAchrome oxidoreductase activity in yellow mice. Journal of Heredity 76:59-60. [Link to abstract]
  105. King RA, Olds DP, 1985, Hairbulb tyrosinase activity in oculocutaneous albinism: suggestions for pathway control and block location. American Journal of Medical Genetics 20:49-55. [Link to abstract]
  106. King RA, Lewis RA, Townsend D, Zelickson A, Olds DP, Brumbaugh JA, 1985, Brown oculocutaneous albinism, Clinical, ophthalmological, and biochemical characterization. Ophthalmology 92:1496-1505. [Link to abstract]
  107. King RA, Olds DP, 1984, Tyrosine uptake in normal and albino hairbulbs. Archives of Dermatological Research 276:313-316. [Link to abstract]
  108. Townsend D, Guillery P, King RA, 1984, Optimized assay for mammalian tyrosinase (polyhydroxyl phenyloxidase). Annals of Biochemistry 139:345-352. [Link to abstract]
  109. Barber JI, Townsend D, Olds DP, King RA, 1984, DOPAchrome oxidoreductase: a new enzyme in the pigment pathway. Journal of Investigative Dermatology 83:145-149. [Link to abstract]
  110. Jimbow K, Ishida O, Ito S, Hori Y, Witkop CJ, King RA, 1983, Combined chemical and electron microscopic studies of pheomelanosomes in human red hair. Journal of Investigative Dermatology 81:506-511. [Link to abstract]
  111. Jay B, Witkop CJ, King RA, 1982, Albinism in England. Birth Defects 1982 18:319-325. [Link to abstract]
  112. Hittner HM, King RA, Riccardi VM, Ledbetter DH, Borda RP, Ferrell RE, Kretzer FL, 1982, Oculocutaneous albinoidism as a manifestation of reduced neural crest derivatives in the Prader-Willi syndrome. American Journal of Ophthalmology 94:328-337. [Link to abstract]
  113. King RA, Olds DP, 1981, Electrophoretic pattern of human hairbulb tyrosinase. Journal of Investigative Dermatology 77:201-204. [Link to abstract]
  114. King RA, Creel DJ, Cervenka J, Okoro AN, Witkop CJ, 1980, Albinism in Nigeria with delineation of new recessive oculocutaneous type. Clinical Genetics 17:259-270. [Link to abstract]
  115. Creel DJ, Garber SR, King RA, Witkop CJ,Jr., 1980, Auditory brainstem anomalies in human albinos. Science 209:1253-1255. [Link to abstract]
  116. Cervenka J, Witkop CJ, Okoro AN, King RA, 1979, Chromosome breaks and sister chromatid exchanges in albinos in Nigeria. Clinical Genetics 15:17-21. [Link to abstract]
  117. O'Donnell FE, King RA, Green WR, Witkop CJ, 1978, Autosomal recessively inherited ocular albinism: A new form of ocular albinism affecting females as severely as males. Archives of Ophthalmology 96:1621-1625. [Link to abstract]
  118. King RA, Olds DP, Witkop CJ, 1978, Characterization of human hairbulb tyrosinase: properties of normal and albino enzyme. Journal of Investigative Dermatology 71:136-139. [Link to abstract]
  119. King RA, Witkop CJ, 1977, Detection of heterozygotes for tyrosinase negative oculocutaneous albinism by hairbulb tyrosinase assay. American Journal of Human Genetics 29:164-168. [Link to abstract]
  120. King RA, Witkop CJ, 1976, Hairbulb tyrosinase activity in oculocutaneous albinism. Nature 263:69-71. [Link to abstract]
  121. Creel DJ, Witkop CJ, King RA, 1974, Asymmetric visually evoked potentials in human albinos: evidence for visual system anomalies. Investigative Ophthalmology 13:430-440. [Link to abstract]
  122. Witkop, C. J.,Jr., White, J. G., and King, R. A, 1974, Oculocutaneous Albinism, in Heritable Disorders of Amino Acid Metabolism, Nyhan, W. L., (ed), John Wiley & Sons, Inc., pp. 177-261.
  123. Witkop CJ, White JG, Gerritsen SM, Townsend D, King RA, 1973, Hermansky-Pudlak Syndrome (HPS): a proposed block in glutathione peroxidase. Oral Surgery 35:790-806. [Link to abstract]